Clinical Trial Update: A Study of SHR-4394 Injection in Subjects With Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for SHR-4394 injection in prostate cancer subjects. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SHR-4394

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING